McIntyre, Freedman & Flynn Investment Advisers’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.53M | Buy |
28,980
+50
| +0.2% | +$4.36K | 1.78% | 20 |
|
|
2025
Q1 | $2.6M | Sell |
28,930
-10
| -0% | -$899 | 1.91% | 22 |
|
|
2024
Q4 | $2.31M | Sell |
28,940
-625
| -2% | -$49.9K | 1.73% | 22 |
|
|
2024
Q3 | $2.66M | Sell |
29,565
-250
| -0.8% | -$22.5K | 1.9% | 20 |
|
|
2024
Q2 | $2.35M | Hold |
29,815
| – | – | 1.69% | 24 |
|
|
2024
Q1 | $2.6M | Buy |
29,815
+800
| +3% | +$69.7K | 1.89% | 20 |
|
|
2023
Q4 | $2.39M | Sell |
29,015
-2,600
| -8% | -$214K | 1.91% | 19 |
|
|
2023
Q3 | $2.48M | Buy |
31,615
+100
| +0.3% | +$7.84K | 2.09% | 17 |
|
|
2023
Q2 | $2.78M | Sell |
31,515
-1,000
| -3% | -$88.1K | 2.37% | 14 |
|
|
2023
Q1 | $2.62M | Buy |
32,515
+3,350
| +11% | +$270K | 2.23% | 18 |
|
|
2022
Q4 | $2.27M | Buy |
+29,165
| New | +$2.27M | 1.88% | 25 |
|